SC 13G | 2022-09-30 | BB BIOTECH AG | Revolution Medicines, Inc. | 4,602,562 | 5.2% | EDGAR |
SC 13G | 2022-06-27 | EcoR1 Capital, LLC | Revolution Medicines, Inc. | 4,278,069 | 5.8% | EDGAR |
SC 13G/A | 2022-05-10 | FMR LLC | Revolution Medicines, Inc. | 186,261 | 0.2% | EDGAR |
SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Revolution Medicines, Inc. | 964,745 | 1.3% | EDGAR |
SC 13G/A | 2022-02-14 | Cormorant Asset Management, LP | Revolution Medicines, Inc. | 886,786 | - | EDGAR |
SC 13G/A | 2022-02-14 | Third Rock Ventures III, L.P. | Revolution Medicines, Inc. | 5,524,031 | 7.5% | EDGAR |
SC 13G/A | 2022-02-11 | COLUMN GROUP III, LP | Revolution Medicines, Inc. | 1,571,963 | 2.1% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Revolution Medicines, Inc. | 6,299,609 | 8.6% | EDGAR |
SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Revolution Medicines, Inc. | 4,510,895 | 6.1% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Revolution Medicines, Inc. | 5,475,219 | 7.4% | EDGAR |
SC 13G/A | 2022-01-10 | FMR LLC | Revolution Medicines, Inc. | 6,101,724 | 8.3% | EDGAR |
SC 13G | 2021-05-19 | Cormorant Asset Management, LP | Revolution Medicines, Inc. | 2,047,079 | - | EDGAR |
SC 13G | 2021-05-17 | BIOTECHNOLOGY VALUE FUND L P | Revolution Medicines, Inc. | 1,966,302 | 2.7% | EDGAR |
SC 13G/A | 2021-02-16 | Cormorant Asset Management, LP | Revolution Medicines, Inc. | 889,287 | - | EDGAR |
SC 13G/A | 2021-02-16 | Boxer Capital, LLC | Revolution Medicines, Inc. | 3,309,264 | 4.6% | EDGAR |
SC 13G | 2021-02-16 | COLUMN GROUP III, LP | Revolution Medicines, Inc. | 1,681,391 | 2.3% | EDGAR |
SC 13G | 2021-02-16 | Third Rock Ventures III, L.P. | Revolution Medicines, Inc. | 1,909,317 | 2.9% | EDGAR |
SC 13G | 2021-02-11 | Sanofi | Revolution Medicines, Inc. | 3,363,050 | 4.6% | EDGAR |
SC 13G | 2021-02-10 | VANGUARD GROUP INC | Revolution Medicines, Inc. | 4,037,820 | 6.1% | EDGAR |
SC 13G/A | 2021-02-08 | FMR LLC | Revolution Medicines, Inc. | 9,339,485 | 14.1% | EDGAR |